1. Selecta Biosciences PowerPoint Presentation

    03:20

    from Selecta Biosciences / Added

    28 Plays / / 0 Comments

    Selecta Biosciences CEO, Werner Cautreels, PhD, provides an overview of Selecta's work to develop next-generation vaccines and immunotherapeutics based on the company's nanoparticle technology. Selecta's proprietary technology creates a new paradigm in immunology, enabling completely new therapeutic applications with the potential for dramatically improved efficacy and safety profiles.

    + More details
    • Selecta Biosciences | Our Nanomedicine Technology: Targeted Immunotherapies and Vaccines

      01:23

      from Selecta Biosciences / Added

      14 Plays / / 0 Comments

      Werner Cautreels, CEO of Selecta Biosciences, provides an overview of Selecta’s approach to developing a new class of next-generation vaccines and immunotherapeutics for a wide range of conditions based on the company’s nanoparticle technology.

      + More details
      • Selecta Biosciences | Our Vision for a New Generation of Vaccines and Immunotherapies

        01:10

        from Selecta Biosciences / Added

        5 Plays / / 0 Comments

        Werner Cautreels, CEO of Selecta Biosciences, explains that the company is developing next-generation nanoparticle-based vaccines and immunotherapeutics to address autoimmune diseases of high unmet need such as type 1 diabetes, life-threatening allergies, and organ transplant rejection

        + More details
        • Werner Cautreels CEO of Selecta Biosciences: World Economic Forum Technology Pioneer 2014 Interview

          03:44

          from Selecta Biosciences / Added

          26 Plays / / 0 Comments

          This is an interview of Werner Cautreels, PhD, President and CEO of Selecta Biosciences. Selecta is a clinical-stage biotechnology company developing a novel class of next-generation vaccines and immunotherapeutics, based on nanoparticle technology, that are synthetically manufactured. Selecta's proprietary technology creates a new paradigm in immunology, enabling completely new therapeutic applications with the potential for dramatically improved efficacy and safety profiles. The company’s synthetic manufacturing process will potentially require less capital and its products will be easier to distribute across the globe. Selecta is building a pipeline of products with a broad range of candidates in infectious diseases, respiratory, oncology, autoimmunity, and allergies. The company’s initial product candidate is a first-in-class synthetic vaccine against nicotine for the critically underserved worldwide market of smoking cessation and relapse prevention. Selecta is developing its novel targeted vaccines and immunotherapies for worldwide markets at our facilities in Watertown, Massachusetts, and Moscow, Russia.

          + More details
          • Selecta Biosciences

            02:19

            from Selecta Biosciences / Added

            30 Plays / / 0 Comments

            Selecta Company Video

            + More details

            What are Tags?

            Tags

            Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."